Location History:
- Padua, IT (2007)
- Padova, IT (2010)
Company Filing History:
Years Active: 2007-2010
Title: The Innovative Contributions of Luca Scorrano
Introduction
Luca Scorrano is a prominent inventor based in Padova, Italy. He has made significant contributions to the field of apoptosis research, holding 2 patents that focus on novel polypeptides and their applications in therapeutic and diagnostic methods.
Latest Patents
Scorrano's latest patents include a method of treating apoptosis and compositions thereof. This invention discloses novel polypeptides and the nucleic acid sequences that encode them. It also includes antibodies that immunospecifically bind to the polypeptide, along with derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Additionally, the invention covers vectors, host cells, antibodies, and recombinant methods for producing the polypeptides and polynucleotides. Methods for using these innovations are also included. Furthermore, the invention discloses therapeutic, diagnostic, and research methods for the diagnosis, treatment, and prevention of apoptosis-associated disorders involving these novel human nucleic acids and proteins. Another significant patent is related to BID polypeptides and methods of inducing apoptosis, which shares similar features and applications as the previous patent.
Career Highlights
Luca Scorrano is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in the field of cancer and apoptosis. His work has been instrumental in understanding the mechanisms of cell death and its implications for cancer treatment.
Collaborations
One of his notable collaborators is Stanley J. Korsmeyer, a respected figure in the field of cancer research. Their partnership has contributed to the advancement of knowledge in apoptosis and its therapeutic applications.
Conclusion
Luca Scorrano's innovative work in the field of apoptosis has led to significant advancements in therapeutic and diagnostic methods. His contributions continue to impact cancer research and treatment strategies.